Joseph Edelman, Director at Cerevel Therapeutics Holdings, Inc. (CERE), bought 1,753,616 shares at $22.81 ($40.0M) on 2023-10-16, disclosed to the SEC on 2023-10-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.81 | 876,808 | $20.0M | 50.0% |
| 2 | $22.81 | 876,808 | $20.0M | 50.0% |
| Total | $22.81 avg | 1,753,616 | $40.0M | 100% |
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |